Based in Lexington, Kentucky, LevTech will be combined with ATMI’s existing LifeSciences business focused on single-use bioprocess containers and processes for the biopharmaceutical industry.
Doug Neugold, CEO of ATMI, said: “The addition of LevTech’s innovative products, intellectual property, and market share puts ATMI’s LifeSciences business in a preeminent position for single-use manufacturing applications in the biopharmaceutical market.”